Oryzon Genomics S.A. (Oryzon) is a biopharmaceutical company. The company develops therapies and biological solutions for cancer and neurodegenerative diseases. It concentrates on the exploitation of biomarkers identified through genomics and proteomics in diagnostics, personalized medicine and therapy fields. Oryzons diagnostic products include GynEC-DX for endometrial cancer; Cxbladder for bladder cancer; and ColoBRAF for colorectal cancer. The company produces NCEs and monoclonal antibodies for neurogeneration and cancer. It collaborates with Eurostarts, Mind, Dendria, Oncologica, Alzheimer Drug Discovery Foundation, among others. Oryzon is headquartered in Barcelona, Spain.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oryzon Genomics S.A.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
We can provide sample pages for the better understanding of this report. Request Sample of This Report, kindly Visit at Oryzon Genomics S.A. - Product Pipeline Analysis, 2014 Update
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Oryzon Genomics S.A. Company Snapshot 4
Oryzon Genomics S.A. Company Overview 4
Key Information 4
Oryzon Genomics S.A. Pipeline Products and Clinical Trials Overview 5
Oryzon Genomics S.A. Pipeline Analysis Overview 7
Key Facts 7
Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis/223510
Oryzon Genomics S.A. - Major Products and Services 8
Oryzon Genomics S.A. Pipeline Products by Development Stage 9
Oryzon Genomics S.A. Pipeline Products Overview 11
Diagnostic Assay - Alzheimer's Disease 11
Diagnostic Assay - Alzheimer's Disease Product Overview 11
Diagnostic Assay - Parkinson's Disease 12
Diagnostic Assay - Parkinson's Disease Product Overview 12
Diagnostic Assay - Stomach Cancer 13
Diagnostic Assay - Stomach Cancer Product Overview 13
Oryzon Diagnostic Test - Prostate Cancer 14
Oryzon Diagnostic Test - Prostate Cancer Product Overview 14
To order report Call +1-518-618-1030 or send an Email on email@example.com